149 related articles for article (PubMed ID: 30537383)
1. Molecular Scaffolds as Double-Targeting Agents For the Diagnosis and Treatment of Neuroblastoma.
Villaverde G; Alfranca A; Gonzalez-Murillo Á; Melen GJ; Castillo RR; Ramírez M; Baeza A; Vallet-Regí M
Angew Chem Int Ed Engl; 2019 Mar; 58(10):3067-3072. PubMed ID: 30537383
[TBL] [Abstract][Full Text] [Related]
2. Novel Meta-iodobenzylguanidine-Based Copper Thiosemicarbazide-1-guanidinomethylbenzyl Anticancer Compounds Targeting Norepinephrine Transporter in Neuroblastoma.
Zhang H; Xie F; Cheng M; Peng F
J Med Chem; 2019 Aug; 62(15):6985-6991. PubMed ID: 31283215
[TBL] [Abstract][Full Text] [Related]
3. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.
Zhang H; Huang R; Cheung NK; Guo H; Zanzonico PB; Thaler HT; Lewis JS; Blasberg RG
Clin Cancer Res; 2014 Apr; 20(8):2182-91. PubMed ID: 24573553
[TBL] [Abstract][Full Text] [Related]
4. Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems.
More SS; Itsara M; Yang X; Geier EG; Tadano MK; Seo Y; Vanbrocklin HF; Weiss WA; Mueller S; Haas-Kogan DA; Dubois SG; Matthay KK; Giacomini KM
Clin Cancer Res; 2011 Apr; 17(8):2339-49. PubMed ID: 21421857
[TBL] [Abstract][Full Text] [Related]
5. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
Seo Y; Gustafson WC; Dannoon SF; Nekritz EA; Lee CL; Murphy ST; VanBrocklin HF; Hernandez-Pampaloni M; Haas-Kogan DA; Weiss WA; Matthay KK
Mol Imaging Biol; 2012 Dec; 14(6):735-42. PubMed ID: 22382618
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of
Das S; Sakhare N; Mathur A; Mallia MB; Mirapurkar S; Sheela M; Sarma HD; Sachdev SS; Dash A
Nucl Med Biol; 2019; 68-69():49-57. PubMed ID: 30770228
[TBL] [Abstract][Full Text] [Related]
7. Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells.
Bayer M; Kuçi Z; Schömig E; Gründemann D; Dittmann H; Handgretinger R; Bruchelt G
Nucl Med Biol; 2009 Apr; 36(3):287-94. PubMed ID: 19324274
[TBL] [Abstract][Full Text] [Related]
8. A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells.
Vaidyanathan G; Welsh PC; Vitorello KC; Snyder S; Friedman HS; Zalutsky MR
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1362-70. PubMed ID: 15205923
[TBL] [Abstract][Full Text] [Related]
9.
Turnock S; Turton DR; Martins CD; Chesler L; Wilson TC; Gouverneur V; Smith G; Kramer-Marek G
Sci Rep; 2020 Dec; 10(1):20918. PubMed ID: 33262374
[TBL] [Abstract][Full Text] [Related]
10. Improved selectivity of mIBG uptake into neuroblastoma cells in vitro and in vivo by inhibition of organic cation transporter 3 uptake using clinically approved corticosteroids.
Bayer M; Schmitt J; Dittmann H; Handgretinger R; Bruchelt G; Sauter AW
Nucl Med Biol; 2016 Sep; 43(9):543-551. PubMed ID: 27376201
[TBL] [Abstract][Full Text] [Related]
11.
Kitamura Y; Baba S; Isoda T; Maruoka Y; Sasaki M; Kamitani T; Koga Y; Kawakubo N; Matsuura T; Ishigami K
Ann Nucl Med; 2021 May; 35(5):549-556. PubMed ID: 33586098
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine does not interfere with meta-iodobenzylguanidine (MIBG) uptake at clinically relevant concentrations.
Batra V; Makvandi M; Zuppa AF; Patel N; Elias J; Pryma DA; Maris JM
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27654664
[TBL] [Abstract][Full Text] [Related]
13. Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors.
Carlin S; Mairs RJ; McCluskey AG; Tweddle DA; Sprigg A; Estlin C; Board J; George RE; Ellershaw C; Pearson AD; Lunec J; Montaldo PG; Ponzoni M; van Eck-Smit BL; Hoefnagel CA; van den Brug MD; Tytgat GA; Caron HN
Clin Cancer Res; 2003 Aug; 9(9):3338-44. PubMed ID: 12960120
[TBL] [Abstract][Full Text] [Related]
14. A new targeting agent for the selective drug delivery of nanocarriers for treating neuroblastoma.
Villaverde G; Baeza A; Melen GJ; Alfranca A; Ramirez M; Vallet-Regí M
J Mater Chem B; 2015 Jun; 3(24):4831-4842. PubMed ID: 32262672
[TBL] [Abstract][Full Text] [Related]
15. [Radio iodized metaiodobenzylguanidine (MIBG) in the treatment of neuroblastoma: modalities and indications].
Défachelles AS; Cougnenc O; Carpentier P
Bull Cancer; 2011 May; 98(5):559-69. PubMed ID: 21609890
[TBL] [Abstract][Full Text] [Related]
16. [131I]meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter.
McCluskey AG; Boyd M; Ross SC; Cosimo E; Clark AM; Angerson WJ; Gaze MN; Mairs RJ
Clin Cancer Res; 2005 Nov; 11(21):7929-37. PubMed ID: 16278418
[TBL] [Abstract][Full Text] [Related]
17. Discovery of dual targeting PEGylated BG-P
Ozen Karakus O; Godugu K; Mousa SA
Bioorg Med Chem; 2021 Aug; 43():116278. PubMed ID: 34157571
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma].
Guerra P
Pediatr Med Chir; 1990; 12(6):663-8. PubMed ID: 2093889
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine transporter-derived homing peptides enable rapid endocytosis of drug delivery nanovehicles into neuroblastoma cells.
Haddad Y; Charousova M; Zivotska H; Splichal Z; Merlos Rodrigo MA; Michalkova H; Krizkova S; Tesarova B; Richtera L; Vitek P; Stokowa-Soltys K; Hynek D; Milosavljevic V; Rex S; Heger Z
J Nanobiotechnology; 2020 Jul; 18(1):95. PubMed ID: 32660596
[TBL] [Abstract][Full Text] [Related]
20. Targeting NCAM-expressing neuroblastoma with polymeric precision nanomedicine.
Markovsky E; Eldar-Boock A; Ben-Shushan D; Baabur-Cohen H; Yeini E; Pisarevsky E; Many A; Aviel-Ronen S; Barshack I; Satchi-Fainaro R
J Control Release; 2017 Mar; 249():162-172. PubMed ID: 28159518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]